DRKS00025242尚未招募不适用
Characteristics of prospective participants and participants in a SARS-CoV-2 vaccination trial (phase I-III): demographics, motivation, attitudes to risk and new technologies
Tropeninstitut am LMU Klinikum0 个研究点目标入组 220 人开始时间: 2021年5月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Definition of Participant (Phase I and Phase II/III): Administration of the investigational product/placebo on day 1 of the vaccination study.
- •Definition of Screen Failure (Phase I and Phase II/III): Exclusion during screening at the trial site.
- •Definition of Interested Person: Expression of interest in participation in vaccination study and provisioning of e-mail address. No invitation to screening.
- •Inclusion criterion for online questionnaire: Belonging to one of the above-mentioned groups as well as completion and sending of the questionnaire.
排除标准
- •Obviously incorrect/inconsistent completion of the questionnaire
研究者
相似试验
已完成
不适用
A prospective, methodology study to identify potential biomarkers of myelin dynamics in CSF using metabolic labeling with stable isotopes in healthy volunteersnerve disease10012303Multiple sclerosisNL-OMON38481Centre for Human Drug Research6
已完成
不适用
Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland DysfunctionMeibomian GlandsNCT01979887Allergan75
尚未招募
不适用
Potential screening participants’ and physicians’ preferences on optimizations of population based colorectal cancer screening, a discrete choice experimentColorectal cancerNL-OMON22227Radboudumc600
招募中
不适用
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)Stargardt DiseaseStargardt Disease 1Cone Rod DystrophyJuvenile Macular DegenerationNCT06445322Ascidian Therapeutics, Inc50
进行中（未招募）
2 期
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBCBreast CancerNCT03439735Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins45